The value of C-reactive protein measurement in rheumatoid arthritis

https://doi.org/10.1016/S0049-0172(05)80003-4Get rights and content

Since 1973, assessment of serum concentrations of C-reactive protein (CRP) has been advocated as a objective measure of disease activity in rheumatoid arthritis (RA). Our review of clinical experience with CRP measurement suggests it has at least two important roles to play in the management of RA. First, persistently elevated CRP levels have prognostic value. In general, such elevated levels are found in those patients who are at greater risk for continuing joint deterioration and therefore may need more aggressive treatment and supportive care. Second, in general, improvement in CRP levels is an objective indication that a drug has produced a beneficial effect and thus may be useful to the physician for monitoring effects of therapy. Since CRP may be elevated in a number of conditions besides RA, a diagnosis of RA must be made before using CRP as a prognostic factor.

References (128)

  • TillettWS et al.

    Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus

    J Exp Med

    (1930)
  • PepysMB et al.

    Acute phase proteins with special reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein

    Adv Immunol

    (1983)
  • BallouSP et al.

    C-reactive protein and the acute phase response

    Adv Intern Med

    (1992)
  • TeboJM et al.

    Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-93

    J Immunol

    (1990)
  • Kolb-BachofenV

    A membrane-bound form of the acute-phase protein C-reactive protein is the galactose-specific particle receptor on rat liver macrophages

    Pathobiology

    (1991)
  • KöttgenE et al.

    Lectin specificity and binding characteristics of human C-reactive protein

    J Immunol

    (1992)
  • SwansonSJ et al.

    Characteristics of the binding of human C-reactive protein (CRP) to laminin

    J Cell Biochem

    (1989)
  • Du ClosTW et al.

    Analysis of the binding of C-reactive protein to chromatin subunits

    J Immunol

    (1991)
  • GitlinJD et al.

    Localization of C-reactive protein in synovium of patients with rheumatoid arthritis

    Arthritis Rheum

    (1977)
  • MurphyTM et al.

    Extrahepatic transcription of human C-reactive protein

    J Exp Med

    (1991)
  • HeinrichPC et al.

    Interleukin-6 and the acute phase response

    Biochem J

    (1990)
  • GanpathiMK et al.

    Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in HEP 3B cells

    J Immunol

    (1991)
  • WendlingD et al.

    Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody

    J Rheumatol

    (1993)
  • BaltzML et al.

    In vivo turnover studies of C-reactive protein

    Clin Exp Immunol

    (1985)
  • VigushinDM et al.

    Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease

    J Clin Invest

    (1993)
  • IannuzziL et al.

    Does drug therapy slow radiographic deterioration in rheumatoid arthritis

    N Engl J Med

    (1983)
  • SharpJT

    Radiologic assessment as an outcome measure in rheumatoid arthritis

    Arthritis Rheum

    (1989)
  • ThonarEJ-MA et al.

    Quantitation of keratan sulfate in blood as a marker of cartilage catabolism

    Arthritis Rheum

    (1985)
  • GoldbergRL et al.

    Elevated plasma levels of hyaluronan in patients with osteoarthritis and rheumatoid arthritis

    Arthritis Rheum

    (1991)
  • WoessnerJF

    Serum hyaluronan: a status report from the joint

    Arthritis Rheum

    (1991)
  • WrightV et al.

    The relevance of acute phase reactants and tests of joint function

    J Drug Dev

    (1991)
  • KushnerI

    C-reactive protein in rheumatology

    Arthritis Rheum

    (1991)
  • ShearnMA et al.

    Effect of age and sex on the erythrocyte sedimentation rate

    J Rheumatol

    (1986)
  • DixonJS

    Relationship between plasma viscosity or ESR and the Ritchie articular index

    Brit J Rheumatol

    (1984)
  • DixonJS et al.

    C-Reactive protein in the serial assessment of disease activity in rheumatoid arthritis

    Scand J Rheumatol

    (1984)
  • TishlerM et al.

    C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy

    Clin Rheumatol

    (1985)
  • Perreira da SilvaJA et al.

    C-Reactive protein levels in systemic lupus erythematosus: a classification criterion?

    Arthritis Rheum

    (1980)
  • YouinouP et al.

    Raised C-reactive protein response in rheumatoid arthritis patients with secondary Sjögren's syndrome

    Rheumatol Int

    (1990)
  • LarsenA

    The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis

    Scand J Rheumatol

    (1988)
  • MallyaRK et al.

    Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate

    J Rheumatol

    (1982)
  • ReebackJS et al.

    Circulating immune complexes and rheumatoid arthritis: A comparison of different assay methods and their early predictive value for disease activity and outcome

    Ann Rheum Dis

    (1985)
  • HightonJ et al.

    Fall in immune complex levels during gold treatment in rheumatoid arthritis

    Ann Rheum Dis

    (1981)
  • ChambersRE et al.

    Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity

    Ann Rheum Dis

    (1983)
  • SukenikS et al.

    Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and noninflammatory arthritis

    J Rheumatol

    (1988)
  • NettelbladtE et al.

    On the relation between serum level of various glycoproteins and the activity of rheumatoid arthritis

    Acta Rheum Scand

    (1962)
  • WaleczekH et al.

    [C-reactive protein in the early diagnosis of post operative infection following bone surgery]

    Chirurg

    (1991)
  • LarssonS et al.

    C-reactive protein (CRP) levels after elective orthopedic surgery

    Clin Orthop

    (1992)
  • HurlimannJ et al.

    The liver as the site of C-reactive protein formation

    J Exp Med

    (1966)
  • ThompsonPW et al.

    Articular indices of joint inflammation in rheumatoid arthritis

    Arthritis Rheum

    (1987)
  • ScottDL et al.

    Progression of radiologic changes in rheumatoid arthritis

    Ann Rheum Dis

    (1984)
  • Cited by (130)

    • Modulatory effect of eugenol on arginase, nucleotidase, and adenosine deaminase activities of platelets in a carrageenan-induced arthritis rat model: A possible anti-arthritic mechanism of eugenol

      2018, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      Also, in ADP hydrolysis and ADA activity showed an increasing effect with slight variation according to doses tested (Figs. 5 and 7). Interestingly, long term use of DEX in inflammatory arthritis has been associated with painful side effects especially on synovial membrane [41]. Thus, eugenol, a natural phenolic compound could be beneficial in ameliorating these observed side effects implicated on this corticoid since both showed similar effects against inflammatory arthritis.

    View all citing articles on Scopus
    1

    From the Department of Immunology and Infectious Diseases, Central Research Division, Pfizer Inc, Groton, CT.

    2

    Ivan G. Otterness, PhD: Research Advisor.

    View full text